Nifty Pharma PB	4.9
Nifty Pharma PE	33.6
Nifty Pharma DIV	0.7
Nifty Pharma EPS	676.8

Nifty Pharma News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Nifty Pharma from all sources in a single place.

Dr. Reddy's Laboratories Ltd.

10 Jan 2026, 07:35PM

1210.10

0.27%

Company Update

Dr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

BSE India

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

pdf

Zydus Lifesciences Ltd.

10 Jan 2026, 02:16PM

894.90

-1.39%

Company Update

Zydus Lifesciences Ltd - 532321 - Update

BSE India

Dissolution of a wholly owned subsidiary of Zydus MedTech (France) S.A.S., which is a step down wholly owned subsidiary of the Company.

pdf

Torrent Pharmaceuticals Ltd.

10 Jan 2026, 09:38AM

3963.40

-1.56%

Torrent Pharma eyes Rs 12,500-crore bond sale next week. Check details

Economic Times

Next week, Torrent Pharmaceuticals is set to launch a hefty debt sale, targeting around 12,500 crore in fundraising. This capital will play a critical role in facilitating the company's acquisition of JB Chemicals & Pharmaceuticals. The strategy includes issuing commercial paper and non-convertible debentures, showcasing the increasing reliance on debt markets for corporate buyouts.

Torrent Pharmaceutic.. has an average target of 3978.00 from 7 brokers.

Sun Pharmaceutical Industries Ltd.

09 Jan 2026, 07:46PM

1729.90

-1.75%

Company Update

Sun Pharmaceutical Industries Ltd - 524715 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Intimation regarding Certificate of Compliance

pdf

Cipla Ltd.

09 Jan 2026, 04:40PM

1465.70

0.35%

Earnings Call

Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 of Securities and Exchange Baord of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Earnings Conference Call to be held on 23rd January, 2026.

pdf

Aurobindo Pharma Ltd.

09 Jan 2026, 03:19PM

1198.70

-0.61%

Company Update

Aurobindo Pharma Ltd - 524804 - Curateq Biologics Receives NOC From Health Canada For Its Biosimilar …

BSE India

Intimation of receipt of Notice of Compliance from Health Canada by Curateq Biologics Private Limited, a wholly owned subsidiary of the Company for its biosimilar Dyrupeg.

pdf

Gland Pharma Ltd.

09 Jan 2026, 12:29PM

1680.60

-0.84%

Company Update

Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Q3FY26 Earnings Call Intimation

pdf

Gland Pharma Ltd.

09 Jan 2026, 12:24PM

1680.60

-0.84%

Board Meeting

Gland Pharma Ltd - 543245 - Board Meeting Intimation for Declaration Of Unaudited Financial Results For …

BSE India

Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve Unaudited Financial Results for the quarter and nine months ended December 31, 2025

pdf

Mankind Pharma Ltd.

09 Jan 2026, 11:53AM

2200.80

-2.67%

Board Meeting

Mankind Pharma Ltd - 543904 - Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated …

BSE India

Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to consider and approve approval of unaudited standalone and consolidated financial results of the company for the quarter and nine months ended on December 31, 2025.

pdf